SCHEMBL1707934

SCHEMBL1707934

CC(=O)O[C@H]1c2ccc(N[C@@H]3COc4c(Nc5cc(C)ccn5)cccc43)cc2OC1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
GAA P10253 2/20 0.37
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 2/20 0.33
ACVRL1 P37023 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
PKM P14618 1/20 0.32
MAP3K12 Q12852 4/20 0.31
KDM4E B2RXH2 2/20 0.30
GLA P06280 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
CRHR1 P34998 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1708342 0.91 NPC1 (0.35) NPC1RAB9ASMN1; SMN2ALDH1A1ACVRL1
SCHEMBL1707969 0.85
SCHEMBL1708436 0.82 P2RX7 (0.30)
SCHEMBL1708500 0.82 P2RX7 (0.32)
SCHEMBL1708581 0.80 POLB (0.31) NPC1RAB9ASMN1; SMN2HSD17B10KDM4E
SCHEMBL1707958 0.80 NPC1 (0.33) NPC1RAB9ASMN1; SMN2GAAHSD17B10
SCHEMBL10010131 0.78 FFAR1 (0.45)
SCHEMBL1707824 0.77 NPC1 (0.37) NPC1RAB9ASMN1; SMN2GAAACVRL1
SCHEMBL1708004 0.77 KCNK3 (0.31)
SCHEMBL3718408 0.77 NPC1 (0.33) NPC1RAB9ASMN1; SMN2GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440541-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2012-04-18 EP disclosed